| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6100729 | Journal of Crohn's and Colitis | 2010 | 5 Pages |
Abstract
Adherence to therapy in inflammatory bowel disease patients is not satisfactory, and worse in patients treated with mesalazine. Optimizing the information on the disease and giving the medication in one or two daily doses could enhance therapeutic adherence.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Fernando Bermejo, Antonio López-San Román, Alicia Algaba, Iván Guerra, Paz Valer, Silvia GarcÃa-Garzón, Belén Piqueras, Carlos Villa, Andrea Bermejo, José L. RodrÃguez-Agulló,